These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3197979)

  • 21. [THE DEFEAT OF BONE TISSUE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES].
    Gabrusskaya TV
    Eksp Klin Gastroenterol; 2016; (2):70-8. PubMed ID: 27301121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of metabolic bone diseases by quantitative computed tomography.
    Richardson ML; Genant HK; Cann CE; Ettinger B; Gordan GS; Kolb FO; Reiser UJ
    Clin Orthop Relat Res; 1985 May; (195):224-38. PubMed ID: 3978956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Casals-Seoane F; Chaparro M; Maté J; Gisbert JP
    Inflamm Bowel Dis; 2016 Aug; 22(8):1929-36. PubMed ID: 27135482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease.
    Motley RJ; Clements D; Evans WD; Crawley EO; Evans C; Rhodes J; Compston JE
    Bone Miner; 1993 Nov; 23(2):95-104. PubMed ID: 8305881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
    Boot AM; Bouquet J; Krenning EP; de Muinck Keizer-Schrama SM
    Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between bone mineral density and clinical features in patients with inflammatory bowel disease: a local study in Turkish population.
    Poturoglu S; Balkan F; Karaali ZE; Ibrisim D; Yanmaz S; Aktuglu MB; Alioglu T; Kendir M
    J Int Med Res; 2010; 38(1):62-8. PubMed ID: 20233514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral content and bone mass in patients with spinal stenosis.
    Johnsson KE; Nilsson BE
    Clin Orthop Relat Res; 1984 Jun; (186):240-3. PubMed ID: 6723152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G; Borte M; Richter T; Kahn T; Borte G
    Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
    Jahnsen J; Falch JA; Aadland E; Mowinckel P
    Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mass in ankylosing spondylitis.
    Reid DM; Nicoll JJ; Kennedy NS; Smith MA; Tothill P; Nuki G
    J Rheumatol; 1986 Oct; 13(5):932-5. PubMed ID: 3820204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease.
    Kotze LM; Costa CT; Cavassani MF; Nisihara RM
    Rev Assoc Med Bras (1992); 2017 Jan; 63(1):13-17. PubMed ID: 28225873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease.
    Turk N; Kastelan D; Cukovic-Cavka S; Kraljevic I; Korsic M; Vucelic B
    Ultrasound Med Biol; 2007 Jun; 33(6):863-9. PubMed ID: 17434664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone-mineral losses in oophorectomized women.
    Dalén N; Lamke B; Wallgren A
    J Bone Joint Surg Am; 1974 Sep; 56(6):1235-8. PubMed ID: 4550050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density and inflammatory bowel disease severity.
    Lima CA; Lyra AC; Mendes CMC; Lopes MB; Coqueiro FG; Rocha R; Santana GO
    Braz J Med Biol Res; 2017 Oct; 50(12):e6374. PubMed ID: 29069227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment.
    Walther F; Fusch C; Radke M; Beckert S; Findeisen A
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):42-51. PubMed ID: 16819376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):23-8. PubMed ID: 24505888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.